Ronald K. Poropatich
Director/Board Member at Noveome Biotherapeutics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Terence C. Golden | M | 79 |
Noveome Biotherapeutics, Inc.
 Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | - |
| David L. Steed | M | - |
Noveome Biotherapeutics, Inc.
Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | - |
| Donald J. Wagner | M | - |
Noveome Biotherapeutics, Inc.
Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | - |
| Patrick Welch | M | - |
Noveome Biotherapeutics, Inc.
Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | 6 years |
| M. Berrey | M | 57 |
Noveome Biotherapeutics, Inc.
Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | 4 years |
| Robert Langer | M | 74 |
Noveome Biotherapeutics, Inc.
Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | - |
| Houman D. Hemmati | M | - |
Noveome Biotherapeutics, Inc.
Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | 2 years |
| Annamaria T. Kausz | M | 60 |
Noveome Biotherapeutics, Inc.
Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | 4 years |
| Kevin E. McCracken | M | - |
Noveome Biotherapeutics, Inc.
Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | 5 years |
| Eric Keller | M | - |
Noveome Biotherapeutics, Inc.
Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| William J. Golden | M | - |
Noveome Biotherapeutics, Inc.
Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | 1 years |
| Chris Harms | M | - |
Drexel University
| 2 years |
| Dan Walsh | M | - |
Drexel University
| 5 years |
| Val de Vassal | M | - |
Drexel University
| 10 years |
| Christopher J. P. Velis | M | - |
Noveome Biotherapeutics, Inc.
Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | - |
| David Paul Wilson | M | 69 |
Drexel University
| 2 years |
| David J. Prilutski | M | - |
Drexel University
| 2 years |
| Fred Kaplan | M | - |
Drexel University
| 2 years |
| Paul McNamara | M | - |
Drexel University
| 5 years |
| Stephen Nickerson | M | - |
Drexel University
| 4 years |
| Bob Moore | M | - |
Drexel University
| 3 years |
| Michael J. Kline | M | - |
Drexel University
| 4 years |
| John J. Palkovitz | M | - |
Drexel University
| 4 years |
| Richard Baum | M | 64 |
Drexel University
| 5 years |
| Nicholas Iacono | M | - |
Drexel University
| 4 years |
| Kemas Muhammad Arief | M | 73 |
Drexel University
| 2 years |
| Shu Kwan Cheng | M | 59 |
Drexel University
| 4 years |
| Eugene March | M | - |
Drexel University
| 4 years |
| Mark McAdoo | M | - |
Drexel University
| 5 years |
| Bruce Culbert | M | - |
Drexel University
| 6 years |
| Joe A. Lorusso | M | - |
Drexel University
| 2 years |
| Joseph F. Comero | M | - |
Drexel University
| 4 years |
| Mike Edwards | M | 64 |
Drexel University
| 4 years |
| Charles Halfpenny | M | - |
Drexel University
| 4 years |
| Ren Liang Gu | M | 67 |
Drexel University
| 1 years |
| Frank Rauch | M | - |
Drexel University
| 5 years |
| Robert May | M | - |
Drexel University
| 5 years |
| Anil S Menawat | M | - |
Drexel University
| 4 years |
| Virginia Gallicchio | F | - |
Drexel University
| 5 years |
| Carlo Brigada | M | 66 |
Drexel University
| 1 years |
| Joseph Aceto | M | 66 |
Drexel University
| 1 years |
| Joseph A. Walicki | M | - |
Drexel University
| 5 years |
| Vincent Fandozzi | M | 59 |
Drexel University
| 4 years |
| Robert A. Cornaglia | M | 56 |
Drexel University
| 4 years |
| Dave Brown | M | - |
Drexel University
| 4 years |
| David R. Laurinaitis | M | - |
Drexel University
| 4 years |
| Kevin B. Michaelis | M | 63 |
Drexel University
| 4 years |
| Lance Roth | M | - |
Drexel University
| 4 years |
| Scott K. Jones | M | - |
Drexel University
| 3 years |
| Hugh Gallagher | M | 61 |
Drexel University
| 5 years |
| Jim Merriam | M | - |
Drexel University
| 2 years |
| Nate Cohen | M | - |
Drexel University
| 4 years |
| Rick H. Hurd | M | - |
Drexel University
| 1 years |
| Keith Creveling | M | - |
Drexel University
| 5 years |
| Sue L. Schnaars | F | - |
Drexel University
| 5 years |
| David Baum | M | - |
Drexel University
| 4 years |
| Mark Lahoda | M | - |
Drexel University
| 2 years |
| Gary F. McManus | M | - |
Drexel University
| 5 years |
| Ken R. Kulju | M | - |
Drexel University
| 2 years |
| John Kerber | M | - |
Drexel University
| 2 years |
| Vijay Ullal | M | 65 |
Drexel University
| 2 years |
| Joseph Michael Warusz | M | 67 |
Drexel University
| 4 years |
| Dan Morris | M | 70 |
Drexel University
| 1 years |
| Kevin O'Hara | M | 63 |
Drexel University
| 4 years |
| James D. Cashel | M | 61 |
Drexel University
| 4 years |
| Philip J. Cavatoni | M | 59 |
Drexel University
| 4 years |
| Phil Garfinkle Garfinkle | M | 63 |
Drexel University
| 4 years |
| Marc L. Rose | M | 59 |
Drexel University
| 4 years |
| Al Altomari | M | 65 |
Drexel University
| 4 years |
| John D. LaRocca | M | - |
Drexel University
| 4 years |
| David M. Harding | M | - |
Drexel University
| 4 years |
| Martin R. Gould | M | 72 |
Drexel University
| 1 years |
| Michael Baum | M | - |
Drexel University
| 5 years |
| John J. Brignola | M | - |
Drexel University
| 2 years |
| Charles Kunsch | M | - |
Drexel University
| 5 years |
| Paul Baiada | M | - |
Drexel University
| 3 years |
| Jim Sonneborn | M | - |
Drexel University
| 2 years |
| Alex Katz | M | 64 |
Drexel University
| 5 years |
| Nancy G. Rogers | F | - |
Drexel University
| 5 years |
| Patrick McGonigal | M | - |
Drexel University
| 4 years |
| James W. Preuninger | M | 64 |
Drexel University
| 4 years |
| Patricia Hordis Sperduto | F | - |
Drexel University
| 4 years |
| Ken Grossman | M | - |
Drexel University
| 4 years |
| Michael Fare | M | - |
Drexel University
| 3 years |
| Michael Hennigan | M | 64 |
Drexel University
| 4 years |
| Stephen M. Wellman | M | - |
Drexel University
| 4 years |
| Julie H. Scribner | F | - |
Drexel University
| 4 years |
| Charles E. deVoe | M | - |
Drexel University
| 4 years |
| Joseph Zakrzewski | M | 60 |
Drexel University
| 4 years |
| Juan Marino | M | - |
Drexel University
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 90 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ronald K. Poropatich
- Personal Network
